Login / Signup

Efficacy and safety of moxidectin-albendazole and ivermectin-albendazole combination therapy compared to albendazole monotherapy in adolescents and adults infected with Trichuris trichiura: a randomized controlled superiority trial.

Viviane P SprecherJean T CoulibalyEveline HürlimannJan HattendorfJennifer Keiser
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
ClinicalTrials.gov (NCT04726969).
Keyphrases
  • combination therapy
  • young adults
  • physical activity
  • study protocol
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label
  • double blind